Corcept Therapeutics Incorporated Gross Profit 2000–2025
Corcept Therapeutics Incorporated reported $748.43M of gross profit for fiscal 2025. That was 12.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +114.9%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $748.43M | 98.3% | +12.7% |
| FY 2024 | $664.16M | 98.4% | +39.6% |
| FY 2023 | $475.89M | 98.7% | +20.0% |
| FY 2022 | $396.47M | 98.7% | +9.9% |
| FY 2021 | $360.70M | 98.6% | +3.6% |
| FY 2020 | $348.29M | 98.4% | +15.7% |
| FY 2019 | $300.98M | 98.2% | +22.3% |
| FY 2018 | $246.03M | 97.9% | +58.1% |
| FY 2017 | $155.65M | 97.8% | +96.4% |
| FY 2016 | $79.26M | 97.5% | +5923.9% |
| FY 2015 | $-1.36M | — | -54.3% |
| FY 2014 | $-882,000 | — | -516.8% |
| FY 2013 | $-143,000 | — | -57.1% |
| FY 2012 | $-91,000 | — | — |
| FY 2011 | — | — | — |
| FY 2010 | — | — | — |
| FY 2009 | — | — | — |
| FY 2008 | — | — | — |
| FY 2007 | — | — | — |
| FY 2006 | — | — | — |
| FY 2005 | — | — | — |
| FY 2004 | — | — | — |
| FY 2003 | — | — | — |
| FY 2002 | — | — | — |
| FY 2001 | — | — | — |
| FY 2000 | — | — | — |
Source: Corcept Therapeutics Incorporated SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CORT 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Corcept Therapeutics Incorporated reported $748.43M of gross profit for fiscal 2025. That was 12.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +114.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Corcept Therapeutics Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCorcept Therapeutics Incorporated — frequently asked questions
What is Corcept Therapeutics Incorporated's gross profit?
Corcept Therapeutics Incorporated (CORT) reported gross profit of $748.43M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Corcept Therapeutics Incorporated's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.